Source: International Congress 2019 – Granulomatous disorders: from bench to bedside
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
J. Donadieu (Paris, France), J. Kabla-Assouline (Créteil, France), R. Chiron (Montpellier, France), S. Héritier (Paris, France), V. Della Valle (Paris, France), C. Delestrain (Créteil, France), M. Kambouchner (Bobigny, France), H. Ducou- Le Pointe (Paris, France), R. Epaud (Créteil, France). Lung involvement in childhood Langerhans cell histiocytosis, A multi-institutional study from the french LCH study group. 5157

Member's Comments

No comment yet.

Related content which might interest you: The long-term outcome of adult pulmonary Langerhans cell histiocytosis: a national registry-based prospective cohort study Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases Year: 2020 Pulmonary langerhans¢ cell histiocytosis (LCH) - a retrospective review of 17 patients Source: Eur Respir J 2003; 22: Suppl. 45, 43s Year: 2003 Chemotherapy in patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Smoking status and long term clinical outcome in patients with pulmonary Langerhans cell histiocytosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Pulmonary Langerhans' cell histiocytosis Source: Respipedia Article Year: 2016 Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Cladribine as a second line treatment in a child with isolated pulmonary Langerhans cell histiocytosis – case report Source: International Congress 2018 – Orphan diseases in children Year: 2018 Genetic landscape of adult Langerhans cell histiocytosis with lung involvement Source: Eur Respir J, 55 (2) 1901190; 10.1183/13993003.01190-2019 Year: 2020 Pneumothorax in patients with Langerhans cell histiocytosis Source: International Congress 2017 – The acute patient: the clinical point-of-view Year: 2017 Paediatric pulmonary Langerhans cell histiocytosis Source: Breathe, 16 (2) 200003; 10.1183/20734735.0003-2020 Year: 2020 Pulmonary Langerhans‘ cell histiocytosis (PLCH): A new UK register Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012 Lung function progression in Langerhans cell histiocytosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012 The proteomic analysis of BAL from patients with langerhans cell histiocytosis (LCH) Source: Eur Respir J 2007; 30: Suppl. 51, 245s Year: 2007 LAM, sarcoidosis, histiocytosis X – rare indications for lung transplantation – a single center experience Source: Eur Respir J 2007; 30: Suppl. 51, 175s Year: 2007 Lung transplantation for pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2005; 26: Suppl. 49, 635s Year: 2005 Treatment dilemmas in sarcoidosis - a retrospective cohort study Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Langerhans cell histiocytosis: is it an ILD? Source: Virtual Congress 2021 – Interstitial lung diseases Year: 2021 Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Influence of pregnancy on pulmonary function in women with pulmonary Langerhans cell histiocytosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013